Loading...
Back to narrative

MOVE: Lower Risk And Steady Margins Will Support Gradual Performance Outlook

Update shared on 11 Dec 2025

Fair value Increased 1.40%
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
42.7%
7D
0.4%

Analysts have modestly raised their price target on Medacta Group to approximately CHF 166.70 from around CHF 164.40, reflecting slightly lower perceived risk, a marginally stronger long term profit margin outlook, and a small upward revision to anticipated future valuation multiples.

Valuation Changes

  • Fair Value has risen slightly from approximately CHF 164.40 to about CHF 166.70, implying a modest increase in the assessed intrinsic value.
  • Discount Rate has fallen marginally from about 4.71 percent to roughly 4.69 percent, indicating a slightly lower perceived risk profile.
  • Revenue Growth remains effectively unchanged at around 12.37 percent, suggesting no material revision to long term top line expectations.
  • Net Profit Margin has risen slightly from about 13.46 percent to roughly 13.56 percent, reflecting a modestly stronger profitability outlook.
  • Future P/E has increased marginally from approximately 32.77x to about 32.92x, signaling a small upward adjustment in expected valuation multiples.

Have other thoughts on Medacta Group?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.